Full Text View
Tabular View
No Study Results Posted
Related Studies
Flupenthixol Decanoate in Methamphetamine Smoking - 1
This study has been completed.
Study NCT00000241   Information provided by National Institute on Drug Abuse (NIDA)
First Received: September 20, 1999   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Substance-Related Disorders
More general conditions related to this trial
Disorders of Environmental Origin
Mental Disorders
Interventions listed in this trial
Flupenthixol
Additional drug interventions recognized in this trial
Amphetamine
Flupenthixol decanoate
Methamphetamine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Uptake Inhibitors
Antipsychotic Agents
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Central Nervous System Stimulants
Dopamine Agents
Dopamine Antagonists
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sympathomimetics
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)
Friends Research Institute, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services